Former EFG Asset Management bond fund manager Roberto Matta has been appointed CEO of new venture capital (VC) firm Evoleen Invest.
Evoleen Invest specialises in health technology investments and is launching its inaugural fund this year, Matta confirmed to Citywire.
The fund will target CHF 60m with a diversified portfolio of between 20 and 30 companies, with key areas to include mental health, chronic diseases and oncology.